Toku
Founded 2019 · 21 employees on LinkedIn · 17 known investors
Toku Eyes develops AI-driven solutions for eye health diagnostics and monitoring, bringing together medical expertise in endocrinology and ophthalmology with artificial intelligence capabilities.
Founders & leadership
Investors · 17
Arc AngelsAuckland
Icehouse VenturesAuckland · $120K – $2.4M
Outset VenturesAuckland · $100K – $10Mvia Mat Rowe · inferred
Blockchain CapitalreportedSan Francisco · $25K – $200K
F-Prime CapitalreportedCambridge · $3M – $10M
Funders Club ManagementreportedSan Francisco
gmjpreported · 2 sourcesWellesley
Gradient Venturesreported · 2 sourcesSan Francisco · $100K – $10M
Next Web Capitalreported · 2 sourcesTokyo
Oak HC/FTreportedStamford
Quantstampreported · 2 sources
Reveriereported · 2 sourcesNew York
Y CombinatorreportedSan Francisco · $500K
Also in the syndicate · 4
ClocktowerOrangeDAOOrrickWollef
Funding
SEC filings, press & company announcements$57.3M disclosed across 2 of 3 rounds · 2023–2025
- $48MSeries AApr 2025 · 2 sourcesSource ↗
- $9.3MraisedApr 2024 · 2 sources
Gradient Ventures (lead), Clocktower, F-Prime Capital, Funders Club, Wollef, Y Combinator
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Toku do?
- Toku Eyes develops AI-driven solutions for eye health diagnostics and monitoring, bringing together medical expertise in endocrinology and ophthalmology with artificial intelligence capabilities.
- Who are Toku's investors?
- Toku's investors include Arc Angels, Icehouse Ventures, Outset Ventures, Blockchain Capital, F-Prime Capital, Funders Club Management, gmjp, Gradient Ventures and 5 more.
- How much funding has Toku raised?
- Toku has disclosed $57.3M raised across 2 of its 3 known rounds.